Activity of CDK4/6 inhibitors in translocation renal cell carcinoma

被引：0
|
作者：
Gupta, S. [1 ]
Khanna, P. [1 ]
Saad, E. [1 ]
Saliby, R. [1 ]
Li, J. [1 ]
Li, B. [1 ]
Sadagopan, A. [1 ]
Xu, Q. [1 ]
Bakouny, Z. [1 ]
Lee, G. S. Mary [1 ]
Choueiri, T. K. [1 ]
Viswanathan, S. R. [1 ]
机构：
[1] Dana Farber Canc Inst, Med Oncol, Boston, MA USA
来源：
EUROPEAN JOURNAL OF CANCER | 2024年 / 211卷
关键词：
D O I：
10.1016/j.ejca.2024.114582
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PB043
引用
收藏
页码：S23 / S23
页数：1
相关论文
共 50 条
  • [1] Therapeutic potential of CDK4/6 inhibitors in renal cell carcinoma
    Sager, Rebecca A.
    Backe, Sarah J.
    Ahanin, Elham
    Smith, Garrett
    Nsouli, Imad
    Woodford, Mark R.
    Bratslaysky, Gennady
    Bourboulia, Dimitra
    Mollapour, Mehdi
    NATURE REVIEWS UROLOGY, 2022, 19 (05) : 305 - 320
  • [2] Therapeutic potential of CDK4/6 inhibitors in renal cell carcinoma
    Rebecca A. Sager
    Sarah J. Backe
    Elham Ahanin
    Garrett Smith
    Imad Nsouli
    Mark R. Woodford
    Gennady Bratslavsky
    Dimitra Bourboulia
    Mehdi Mollapour
    Nature Reviews Urology, 2022, 19 : 305 - 320
  • [3] CDK4/6 inhibitors
    不详
    CHEMICAL & ENGINEERING NEWS, 2016, : 30 - 31
  • [4] Targeting PIM1 and CDK4/6 kinases in renal cell carcinoma
    Small, Jeffery S.
    Holder, Sheldon L.
    CANCER RESEARCH, 2015, 75
  • [5] CDK4 as a Prognostic Marker of Hepatocellular Carcinoma and CDK4 Inhibitors as Potential Therapeutics
    Lai, Fobao
    Fang, Yingbing
    Cheng, Cong
    Zhong, Xuejing
    Zheng, Wanrong
    Lan, Shiqian
    Peng, Quanshui
    Cai, Xiumei
    Cao, Tiantian
    Zhong, Chengqian
    Gao, Yuzhen
    CURRENT MEDICINAL CHEMISTRY, 2025, 32 (02) : 343 - 358
  • [6] CDK4/6 Inhibition With Abemaciclib in Patients With Previously Treated Advanced Renal Cell Carcinoma
    Mcgregor, Bradley A.
    Xie, Wanling
    Berg, Stephanie A.
    Xu, Wenxin
    Viswanathan, Srinivas R.
    Mcdermott, David
    Signoretti, Sabina
    Kaelin, William G.
    Choueiri, Toni K.
    CLINICAL GENITOURINARY CANCER, 2025, 23 (03)
  • [7] CDK4/6 inhibitors prolong OS
    Killock, David
    NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (12) : 722 - 722
  • [8] CDK4/6 inhibitors: The Devil is in the Detail
    Magge, Tara
    Rajendran, Sneha
    Brufsky, Adam M.
    Foldi, Julia
    CURRENT ONCOLOGY REPORTS, 2024, 26 (06) : 665 - 678
  • [9] Development and strategies of CDK4/6 inhibitors
    Chen, Pingping
    Xu, Yinqiu
    Li, Xuanyi
    Yao, Hequan
    Lin, Kejiang
    FUTURE MEDICINAL CHEMISTRY, 2020, 12 (02) : 127 - 145
  • [10] Immunomodulatory effects of CDK4/6 inhibitors
    Zhang, Shumeng
    Xu, Qiaomai
    Sun, Wenjia
    Zhou, Jianya
    Zhou, Jianying
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (04):
12345